Table 3.
Association between severe AKI status and patient characteristics among neonates with NEC in the neonatal intensive care unit, 2013–2018.
Associated factors | Unadjusted model |
Adjusted model |
||||
---|---|---|---|---|---|---|
OR | 95% CI | P value | aOR | 95% CI | P value | |
PIH | 2.61 | 1.22–5.61 | 0.01 | 1.29 | 0.43–3.82 | 0.65 |
Antenatal steroids | 2.35 | 1.23–4.67 | 0.01 | 3.05 | 1.14–8.87 | 0.03 |
Gestational age (weeks) | 0.89 | 0.82–0.96 | 0.003 | 0.91 | 0.80–1.01 | 0.10 |
Birth weight | 0.99 | 0.99–0.99 | 0.001 | — | — | — |
Male | 1.58 | 0.86–2.92 | 0.15 | 1.53 | 0.57–4.14 | 0.40 |
Outborn | 2.51 | 1.31–4.82 | 0.006 | 3.95 | 1.54–11.01 | 0.006 |
Pneumatosis | 1.08 | 0.59–1.97 | 0.80 | 1.10 | 0.40–2.94 | 0.86 |
Surgical NEC | 26.39 | 9.9–70.36 | <0.001 | 30.68 | 8.98–130.67 | <0.001 |
Positive blood culture | 2.47 | 1.31–4.67 | 0.005 | 3.50 | 1.31–10.04 | 0.02 |
Vancomycin | 0.61 | 0.27–1.37 | 0.23 | 0.41 | 0.08–1.90 | 0.26 |
Pneumoperitoneum | 2.64 | 1.39–5.06 | 0.003 | 0.48 | 0.16–1.40 | 0.19 |
Gentamicin | 0.33 | 0.17–0.63 | 0.001 | 0.31 | 0.10–0.88 | 0.03 |
Amikacin | 0.60 | 0.30–1.21 | 0.15 | 0.63 | 0.18–2.18 | 0.47 |
Duration of antibiotics | 1.03 | 0.98–1.10 | 0.17 | 0.99 | 0.89–1.09 | 0.85 |
AKI acute kidney injury, aOR adjusted odds ratio, PIH pregnancy-induced hypertension, CI confidence interval.
For gestational age, aOR wasbased on a 1-week change in gestational age; for birth weight unadjusted, aOR was based on 100 g change in birth weight; for the duration of antibiotics, aOR was based on a 1-day change in exposure to nephrotoxic antibiotics following NEC diagnosis.